Pendopharm, a division of Pharmascience Inc., is pleased to announce that it has entered into an exclusive distribution ...

The threat of 200 per cent tariffs is weighing heavily on the Canadian pharmaceutical industry. They worry that drug prices ...

Already, the pharmaceutical sector accounts for nearly seven per cent of Manitoba’s GDP. Pfizer, Bausch Health and Dynacare ...

Total consideration for the acquisition will range between $3 million and $3.3 million and involves a nominal cash payment as well as assumption of Target Co.'s bank debt.

Experts say the system of EDRDs incentivizes companies to manufacture these drugs due to the high prices that can be charged ...

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and ...

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) ...